DAA Supports Recent Changes to the Affordable Care Act

January 08, 2024

To Whom It May Concern:

"The undersigned members of the Diabetes Advocacy Alliance (DAA) are writing to express our support for various provisions of the Notice of Benefit and Payment Parameters (NBPP) for 2025, specifically moving from USP Medicare Model Guidelines (MMG) to the USP Drug Classification (USP DC) system for use in the essential health benefit (EHB) package described in section 1302(a) of the Affordable Care Act (ACA). As you may know, there are about 38 million people living with diabetes in the United States, and it is estimated that about 98 million U.S. adults have prediabetes.1 We appreciate that CMS is considering moving to the USP DC, as such a move would have great benefits for the millions of people living with prediabetes and diabetes."

arrow Read the Full Letter

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.